Simon Cervenka

About me
Publications
CV
Public outreach and news

About me

I am an associate professor and senior clinical lecturer in psychiatry at KI,
and consultant in Psychiatry at Psykiatri Nordväst. Since 2018, I am
leading a multidisciplinary research group focusing on molecular imaging
and psychosis research.
Medical degree, Uppsala University, 1999
Licence to practice medicine, 2002
PhD, Department of Clinical Neuroscience, Karolinska Institutet, 2008
Specialist in General Psychiatry, 2009
Guest Researcher, University of Cambridge, 2015-2016
Associate Professor in Psychiatry, 2016

Research

My research is dedicated to finding new methods of diagnosis and treatment of
psychotic disorders. The main approach is to use Positron Emission
Tomography (PET) but extending also to other imaging modalities and
methods. The research is carried out within Centre for Psychiatry
Research, in close collaboration with health care partners.

Teaching

I am responsible for the psychiatry course at the MD programme at Karolinska
Institutet, site Solna.

Articles

Article: BRAIN BEHAVIOR AND IMMUNITY. 2023;111:376-385

Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity.

Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Article: ADDICTION. 2023;118(6):1053-1061

Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers.

Jangard S; Jayaram-Lindström N; Isacsson NH; Matheson GJ; Plavén-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(14):e2213880120

Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium.

Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Hulshoff Pol HE; Kahn RS; Ayesa-Arriola R; Ortiz-García de la Foz V; Tordesillas-Gutierrez D; Vázquez-Bourgon J; Crespo-Facorro B; Alnæs D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jönsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quidé Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; de Haan L; Brosch K; Pfarr J-K; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadić I; Krämer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarró S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim W-S; Chung Y-C; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Fazio L; Pergola G; Bertolino A; Díaz-Caneja CM; Janssen J; Lois NG; Arango C; Tomyshev AS; Lebedeva I; Cervenka S; Sellgren CM; Georgiadis F; Kirschner M; Kaiser S; Hajek T; Skoch A; Spaniel F; Kim M; Kwak YB; Oh S; Kwon JS; James A; Bakker G; Knöchel C; Stäblein M; Oertel V; Uhlmann A; Howells FM; Stein DJ; Temmingh HS; Diaz-Zuluaga AM; Pineda-Zapata JA; López-Jaramillo C; Homan S; Ji E; Surbeck W; Homan P; Fisher SE; Franke B; Glahn DC; Gur RC; Hashimoto R; Jahanshad N; Luders E; Medland SE; Thompson PM; Turner JA; van Erp TGM; Francks C
Article: CLINICAL PSYCHOLOGY & PSYCHOTHERAPY. 2023;30(2):486-490

Metacognitive training for negative symptoms: Support for the cognitive model.

Swanson L; Griffiths H; Moritz S; Cervenka S
Article: NATURE COMMUNICATIONS. 2022;13(1):6427

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.

Gracias J; Orhan F; Hörbeck E; Holmén-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel İŞ; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yañez VAC; Göpfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM
Article: HELIYON. 2022;8(9):e10424

Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms.

Larsson C; Lee M; Lundgren T; Erhardt S; Sellgren CM; Cervenka S; Borg J; Bölte S; Fatouros-Bergman H
Article: MOLECULAR PSYCHIATRY. 2022;27(8):3247-3261

Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia.

Mätlik K; Garton DR; Montaño-Rodríguez AR; Olfat S; Eren F; Casserly L; Damdimopoulos A; Panhelainen A; Porokuokka LL; Kopra JJ; Turconi G; Schweizer N; Bereczki E; Piehl F; Engberg G; Cervenka S; Piepponen TP; Zhang F-P; Sipilä P; Jakobsson J; Sellgren CM; Erhardt S; Andressoo J-O
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2022;151:571-574

Cytomegalovirus infection associated with lower IQ in adolescent patients with schizophrenia spectrum disorders: A preliminary report.

Calkova T; Cervenka S; Yolken RH; Andreassen OA; Andreou D
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):229

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients.

Shang P; Ho AM-C; Tufvesson-Alm M; Lindberg DR; Grant CW; Orhan F; Eren F; Bhat M; Engberg G; Schwieler L; Fatouros-Bergman H; Imbeault S; Iverson RM; Dasari S; Piehl F; Cervenka S; Sellgren CM; Erhardt S; Choi D-S
Article: MOLECULAR PSYCHIATRY. 2022;27(2):1233-1240

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.

Plavén-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
Article: HUMAN BRAIN MAPPING. 2022;43(1):352-372

A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium.

Gutman BA; van Erp TGM; Alpert K; Ching CRK; Isaev D; Ragothaman A; Jahanshad N; Saremi A; Zavaliangos-Petropulu A; Glahn DC; Shen L; Cong S; Alnaes D; Andreassen OA; Doan NT; Westlye LT; Kochunov P; Satterthwaite TD; Wolf DH; Huang AJ; Kessler C; Weideman A; Nguyen D; Mueller BA; Faziola L; Potkin SG; Preda A; Mathalon DH; Bustillo J; Calhoun V; Ford JM; Walton E; Ehrlich S; Ducci G; Banaj N; Piras F; Piras F; Spalletta G; Canales-Rodríguez EJ; Fuentes-Claramonte P; Pomarol-Clotet E; Radua J; Salvador R; Sarró S; Dickie EW; Voineskos A; Tordesillas-Gutiérrez D; Crespo-Facorro B; Setién-Suero E; van Son JM; Borgwardt S; Schönborn-Harrisberger F; Morris D; Donohoe G; Holleran L; Cannon D; McDonald C; Corvin A; Gill M; Filho GB; Rosa PGP; Serpa MH; Zanetti MV; Lebedeva I; Kaleda V; Tomyshev A; Crow T; James A; Cervenka S; Sellgren CM; Fatouros-Bergman H; Agartz I; Howells F; Stein DJ; Temmingh H; Uhlmann A; de Zubicaray GI; McMahon KL; Wright M; Cobia D; Csernansky JG; Thompson PM; Turner JA; Wang L
Article: HUMAN BRAIN MAPPING. 2022;43(1):431-451

Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years.

Frangou S; Modabbernia A; Williams SCR; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodríguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dale AM; Dannlowski U; Davey C; de Geus EJC; de Haan L; de Zubicaray GI; den Braber A; Dickie EW; Di Giorgio A; Doan NT; Dørum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Hahn T; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Hulshoff Pol HE; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jönsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Krämer B; Kuntsi J; Lagopoulos J; Lázaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martínez-Zalacaín I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Meinert S; Menchón JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sánchez-Juan P; Sarró S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutiérrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; van 't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Völzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Karolinska Schizophrenia Project (KaSP); Thompson PM; Dima D
Article: HUMAN BRAIN MAPPING. 2022;43(1):452-469

Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years.

Dima D; Modabbernia A; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodríguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dannlowski U; Dale AM; Davey C; de Geus EJC; de Haan L; de Zubicaray GI; den Braber A; Dickie EW; Di Giorgio A; Doan NT; Dørum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Hahn T; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Hulshoff Pol HE; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jönsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Krämer B; Kuntsi J; Lagopoulos J; Lázaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martínez-Zalacaín I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Meinert S; Menchón JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sánchez-Juan P; Sarró S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutiérrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; Van't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Völzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Williams SCR; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Thompson PM; Frangou S; Karolinska Schizophrenia Project (KaSP)
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):566

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis.

Theorell J; Ramberger M; Harrison R; Mgbachi V; Jacobson L; Waters P; Erhardt S; Sellgren CM; Cervenka S; Piehl F; Irani SR
Article: MOLECULAR PSYCHIATRY. 2021;26(11):6820-6832

GRK3 deficiency elicits brain immune activation and psychosis.

Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hökfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landén M; Engberg G; Erhardt S
Article: NPJ SCHIZOPHRENIA. 2021;7(1):46

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis.

Lee M; Fatouros-Bergman H; Plavén-Sigray P; Ikonen Victorsson P; Sellgren CM; Erhardt S; Flyckt L; Farde L; Cervenka S
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(5):315-322

Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences.

Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lähteenvuo M
Article: SCIENTIFIC REPORTS. 2021;11(1):7527

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis.

Becklén M; Orhan F; Piehl F; Cervenka S; Sellgren CM; Flyckt L; Erhardt S; Fatouros-Bergman H
Article: JOURNAL OF NUCLEAR MEDICINE. 2021;62(3):412-417

Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies.

Laurell GL; Plavén-Sigray P; Jucaite A; Varrone A; Cosgrove KP; Svarer C; Knudsen GM; Karolinska Schizophrenia Project Consortium; Ogden RT; Zanderigo F; Cervenka S; Hillmer AT; Schain M
Article: NEUROIMAGE. 2021;226:117523

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457.

Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Article: NATURE AND SCIENCE OF SLEEP. 2021;13:775-789

Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation.

Tamm S; Lensmar C; Andreasson A; Axelsson J; Forsberg Morén A; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Olgart Höglund C; Strand V; Cervenka S; Lekander M
Article: BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING. 2020;5(12):1095-1103

Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study.

Tønnesen S; Kaufmann T; de Lange A-MG; Richard G; Doan NT; Alnæs D; van der Meer D; Rokicki J; Moberget T; Maximov II; Agartz I; Aminoff SR; Beck D; Barch DM; Beresniewicz J; Cervenka S; Fatouros-Bergman H; Craven AR; Flyckt L; Gurholt TP; Haukvik UK; Hugdahl K; Johnsen E; Jönsson EG; Karolinska Schizophrenia Project; Kolskår KK; Kroken RA; Lagerberg TV; Løberg E-M; Nordvik JE; Sanders A-M; Ulrichsen K; Andreassen OA; Westlye LT
Article: EJNMMI RESEARCH. 2020;10(1):95

Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson's disease.

Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Article: NATURE COMMUNICATIONS. 2020;11(1):4016

The genetic architecture of human brainstem structures and their involvement in common brain disorders.

Elvsåshagen T; Bahrami S; van der Meer D; Agartz I; Alnæs D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Bøen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Håberg A; Heslenfeld D; Hoekstra PJ; Høgestøl EA; Jonassen R; Jönsson EG; Karolinska Schizophrenia Project (KaSP) consortium; Kirsch P; Kłoszewska I; Lagerberg TV; Landrø NI; Le Hellard S; Lesch K-P; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; Connell KSO; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbæk G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T
Article: SCHIZOPHRENIA RESEARCH. 2020;222:175-184

Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness.

Matheson GJ; Plavén-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):77

Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability.

Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(12):1756-1761

Synthesis and Preclinical Evaluation of 6-[18F]Fluorine-α-methyl-l-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake.

Krasikova R; Kondrashov M; Avagliano C; Petukhov M; Vazquez-Romero A; Revunov E; Johnström P; Tari L; Tóth M; Häggkvist J; Erhardt S; Cervenka S; Schou M
Article: IBRO REPORTS. 2020;8:136-142

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.

Xu C; Sellgren CM; Fatouros-Bergman H; Piehl F; Blennow K; Zetterberg H; Brinkmalm A; Santillo AF; Lundgren S; Cervenka S; Engberg G; Erhardt S; Karolinska Schizophrenia Project (KaSP) Consortium
Article: NEUROIMAGE. 2019;202:116143

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain.

Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(11):2329-2338

Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study.

Tuisku J; Plavén-Sigray P; Gaiser EC; Airas L; Al-Abdulrasul H; Brück A; Carson RE; Chen M-K; Cosgrove KP; Ekblad L; Esterlis I; Farde L; Forsberg A; Halldin C; Helin S; Kosek E; Lekander M; Lindgren N; Marjamäki P; Rissanen E; Sucksdorff M; Varrone A; HRRT [11C ]PBR28 study group; Collste K; Gallezot J-D; Hillmer A; Huang Y; Höglund CO; Johansson J; Jucaite A; Lampa J; Nabulsi N; Pittman B; Sandiego CM; Stenkrona P; Rinne J; Matuskey D; Cervenka S
Article: NATURE NEUROSCIENCE. 2019;22(10):1617-1623

Common brain disorders are associated with heritable patterns of apparent aging of the brain.

Kaufmann T; van der Meer D; Doan NT; Schwarz E; Lund MJ; Agartz I; Alnæs D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Bøen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Córdova-Palomera A; Dale AM; de Quervain DJF; Di Carlo P; Djurovic S; Dørum ES; Eisenacher S; Elvsåshagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Håberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Høgestøl EA; Jernigan TL; Jonassen R; Jönsson EG; Karolinska Schizophrenia Project (KaSP); Kirsch P; Kłoszewska I; Kolskår KK; Landrø NI; Le Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbæk G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT
Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;334:577000

Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C]PBR28 positron emission tomography.

Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
Article: SCHIZOPHRENIA RESEARCH. 2019;210:221-227

Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.

Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; Karolinska Schizophrenia Project (KaSP) consortium; Erhardt S
Article: JAMA PSYCHIATRY. 2019;76(7):739-748

Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.

Alnæs D; Kaufmann T; van der Meer D; Córdova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Doan NT; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jönsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT; Karolinska Schizophrenia Project Consortium
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(7):415-425

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.

Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Article: NEUROIMAGE. 2019;188:102-110

Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Plavén-Sigray P; Schain M; Zanderigo F; Karolinska [(11)C]PBR28 study group; Rabiner EA; Gunn RN; Ogden RT; Cervenka S
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):12

Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder.

Schwarz E; Doan NT; Pergola G; Westlye LT; Kaufmann T; Wolfers T; Brecheisen R; Quarto T; Ing AJ; Di Carlo P; Gurholt TP; Harms RL; Noirhomme Q; Moberget T; Agartz I; Andreassen OA; Bellani M; Bertolino A; Blasi G; Brambilla P; Buitelaar JK; Cervenka S; Flyckt L; Frangou S; Franke B; Hall J; Heslenfeld DJ; Kirsch P; McIntosh AM; Nöthen MM; Papassotiropoulos A; de Quervain DJ-F; Rietschel M; Schumann G; Tost H; Witt SH; Zink M; Meyer-Lindenberg A; IMAGEMEND Consortium, Karolinska Schizophrenia Pro
Article: BRAIN BEHAVIOR AND IMMUNITY. 2019;75:72-83

Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.

Albrecht DS; Forsberg A; Sandström A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Höglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
Article: EJNMMI RESEARCH. 2018;8(1):102

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Plavén-Sigray P; Matheson GJ; Cselényi Z; Jucaite A; Farde L; Cervenka S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(9):644-654

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Bustillo JR; Clark VP; Agartz I; Mueller BA; Cahn W; de Zwarte SMC; Hulshoff Pol HE; Kahn RS; Ophoff RA; van Haren NEM; Andreassen OA; Dale AM; Doan NT; Gurholt TP; Hartberg CB; Haukvik UK; Jørgensen KN; Lagerberg TV; Melle I; Westlye LT; Gruber O; Kraemer B; Richter A; Zilles D; Calhoun VD; Crespo-Facorro B; Roiz-Santiañez R; Tordesillas-Gutiérrez D; Loughland C; Carr VJ; Catts S; Cropley VL; Fullerton JM; Green MJ; Henskens FA; Jablensky A; Lenroot RK; Mowry BJ; Michie PT; Pantelis C; Quidé Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Shannon Weickert C; Weickert TW; Morris DW; Hong E; Kochunov P; Beard LM; Gur RE; Gur RC; Satterthwaite TD; Wolf DH; Belger A; Brown GG; Ford JM; Macciardi F; Mathalon DH; O'Leary DS; Potkin SG; Preda A; Voyvodic J; Lim KO; McEwen S; Yang F; Tan Y; Tan S; Wang Z; Fan F; Chen J; Xiang H; Tang S; Guo H; Wan P; Wei D; Bockholt HJ; Ehrlich S; Wolthusen RPF; King MD; Shoemaker JM; Sponheim SR; De Haan L; Koenders L; Machielsen MW; van Amelsvoort T; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; McKenna PJ; Pomarol-Clotet E; Salvador R; Corvin A; Donohoe G; Kelly S; Whelan CD; Dickie EW; Rotenberg D; Voineskos AN; Ciufolini S; Radua J; Dazzan P; Murray R; Reis Marques T; Simmons A; Borgwardt S; Egloff L; Harrisberger F; Riecher-Rössler A; Smieskova R; Alpert KI; Wang L; Jönsson EG; Koops S; Sommer IEC; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Stephen JM; Kwon JS; Yun J-Y; Cannon DM; McDonald C; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Karolinska Schizophrenia Project; Busatto GF; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; Hagenaars SP; McIntosh AM; Whalley HC; Lawrie SM; Knöchel C; Oertel-Knöchel V; Stäblein M; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; McMahon A; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(5):432-440

Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.

Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium; Engberg G; Erhardt S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(6):433-442

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):74

[11C]SCH23390 binding to the D1-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis.

Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
Article: MOLECULAR PSYCHIATRY. 2018;23(5):1244-1250

CSF GABA is reduced in first-episode psychosis and associates to symptom severity.

Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
Article: BRAIN BEHAVIOR AND IMMUNITY. 2018;68:146-157

Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [11C]PBR28 PET study.

Tamm S; Cervenka S; Forsberg A; Estelius J; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Lensmar C; Strand V; Åkerstedt T; Halldin C; Ingvar M; Olgart Höglund C; Lekander M
Article: PSYCHOLOGICAL MEDICINE. 2018;48(1):82-94

Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.

Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santiañez R; Crespo-Facorro B; Suarez-Pinilla P; van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jørgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Færden A; Flyckt L; Fatouros-Bergman H; Karolinska Schizophrenia Project Consortium (KaSP); Jönsson EG; Hashimoto R; Yamamori H; Fukunaga M; Jahanshad N; De Rossi P; Piras F; Banaj N; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Krämer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: PEERJ. 2018;6:e5790

Serotonin 5-HT1A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing.

Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2018;10:678-687

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E; Bethlehem RAI; Romero-Garcia R; Cervenka S; Rittman T; Gabel S; Surendranathan A; Bevan-Jones RW; Passamonti L; Vázquez Rodríguez P; Su L; Arnold R; Williams GB; Hong YT; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
Article: PLOS ONE. 2018;13(12):e0209584

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.

Caravaggio F; Plavén-Sigray P; Matheson GJ; Plitman E; Chakravarty MM; Borg J; Graff-Guerrero A; Cervenka S
Article: PLOS ONE. 2018;13(3):e0193770

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study.

Plavén-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Article: EJNMMI RESEARCH. 2017;7(1):58

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data.

Matheson GJ; Plavén-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: LECTURE NOTES IN COMPUTER SCIENCE. 2017;10541:371-378

Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.

Petrov D; Gutman BA; Yu S-HJ; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreasen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutiérrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rössler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodríguez EJ; Salvador R; Huang AJ; Roiz-Santiañez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM
Article: NEUROIMAGE. 2017;155:344-353

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390.

Matheson GJ; Stenkrona P; Cselényi Z; Plavén-Sigray P; Halldin C; Farde L; Cervenka S
Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856

Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.

Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Karolinska Schizophrenia Project (KaSP) consortium; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2017;135(5):439-447

Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.

Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santiañez R; Crespo-Facorro B; Suarez-Pinilla P; Van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jørgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Mørch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Karolinska Schizophrenia Project Consortium (KaSP); Jönsson EG; Hashimoto R; Yamamori H; Fukunaga M; Preda A; De Rossi P; Piras F; Banaj N; Ciullo V; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Krämer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469

Extrastriatal dopamine D2-receptor availability in social anxiety disorder.

Plavén-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Rück C; Halldin C; Lindefors N; Cervenka S
Article: TRANSLATIONAL PSYCHIATRY. 2017;7(4):e1104

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.

Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström A-L; Franck J
Article: ANNALS OF NEUROLOGY. 2017;81(4):572-582

The immune response of the human brain to abdominal surgery.

Forsberg A; Cervenka S; Jonsson Fagerlund M; Rasmussen LS; Zetterberg H; Erlandsson Harris H; Stridh P; Christensson E; Granström A; Schening A; Dymmel K; Knave N; Terrando N; Maze M; Borg J; Varrone A; Halldin C; Blennow K; Farde L; Eriksson LI
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(5):262-271

Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll-like Receptor Stimulation in Peripheral Monocytes.

Orhan F; Bhat M; Sandberg K; Ståhl S; Piehl F; Karolinska Schizophrenia Project (KaSP) consortium; Svensson C; Erhardt S; Schwieler L
Article: MOLECULAR PSYCHIATRY. 2016;21(8):1077-1084

Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.

Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jönsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;54:149-157

In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.

Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Olgart Höglund C; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(1):173-183

Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects.

Collste K; Forsberg A; Varrone A; Amini N; Aeinehband S; Yakushev I; Halldin C; Farde L; Cervenka S
Article: JAMA PSYCHIATRY. 2015;72(7):659-667

D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.

Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
Article: NEUROIMAGE. 2015;112:225-231

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects.

Matheson GJ; Schain M; Almeida R; Lundberg J; Cselényi Z; Borg J; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2014;102 Pt 2:590-595

Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study.

Plavén-Sigray P; Gustavsson P; Farde L; Borg J; Stenkrona P; Nyberg L; Bäckman L; Cervenka S
Article: SCHIZOPHRENIA RESEARCH. 2014;158(1-3):156-162

Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia.

Fatouros-Bergman H; Cervenka S; Flyckt L; Edman G; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(4):763-769

Effects of amphetamine on the human brain opioid system--a positron emission tomography study.

Guterstam J; Jayaram-Lindström N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
Article: NEUROIMAGE. 2013;67:1-6

Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum.

de Manzano Ö; Cervenka S; Jucaite A; Hellenäs O; Farde L; Ullén F
Article: TRANSLATIONAL PSYCHIATRY. 2012;2(5):e120

Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder.

Cervenka S; Hedman E; Ikoma Y; Djurfeldt DR; Rück C; Halldin C; Lindefors N
Article: JOURNAL OF NEUROIMAGING. 2012;22(1):28-32

A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry.

Comley RA; Cervenka S; Palhagen SE; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L; Nichols TE; Whitcher BJ
Article: SYNAPSE. 2010;64(6):478-485

PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.

Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
Article: PLOS ONE. 2010;5(5):e10670

Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals.

de Manzano O; Cervenka S; Karabanov A; Farde L; Ullén F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(16):7574-7579

Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning.

Karabanov A; Cervenka S; de Manzano O; Forssberg H; Farde L; Ullén F
Article: NEUROIMAGE. 2010;50(1):323-328

Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.

Cervenka S; Gustavsson JP; Halldin C; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2008;11(5):671-678

Age-related diurnal effect on D2 receptor binding: a preliminary PET study.

Cervenka S; Halldin C; Farde L
Article: NEUROIMAGE. 2008;40(3):1287-1295

Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum.

Cervenka S; Bäckman L; Cselényi Z; Halldin C; Farde L
Article: LAKARTIDNINGEN. 2007;104(26-27):2002-2003

[Coming generation of researchers--a question of fate for psychiatry].

Cervenka S; Reutfors J; Lundberg J; Papadopoulos F; Lundén E; Sjöström C; Björklund L
Article: BRAIN. 2006;129(Pt 8):2017-2028

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2004;175(2):148-153

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.

Talvik M; Nordström A-L; Larsen N-E; Jucaite A; Cervenka S; Halldin C; Farde L
Show more

All other publications

Letter: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2022;76(10):526-527

No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation: A Swedish registry study.

Ekström LD; Pahnke S; Larfors G; Hägglund H; Lekander M; Edgren G; Cervenka S
Review: BJPSYCH OPEN. 2022;8(5):e159

Exhaustion disorder: scoping review of research on a recently introduced stress-related diagnosis.

Lindsäter E; Svärdman F; Wallert J; Ivanova E; Söderholm A; Fondberg R; Nilsonne G; Cervenka S; Lekander M; Rück C
Review: TRANSLATIONAL PSYCHIATRY. 2022;12(1):248

Application of positron emission tomography in psychiatry-methodological developments and future directions.

Cervenka S; Frick A; Bodén R; Lubberink M
Corrigendum: MOLECULAR PSYCHIATRY. 2022;27(3):1855

Correction: GRK3 deficiency elicits brain immune activation and psychosis.

Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hökfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landén M; Engberg G; Erhardt S
Editorial comment: BRAIN BEHAVIOR AND IMMUNITY. 2021;93:8-9

Effects of acute glial cell activation on memory performance - Implications for treatment of cognitive symptoms in neurological and psychiatric disorders.

Cervenka S
Letter: BIOLOGICAL PSYCHIATRY. 2021;89(3):e5-e8

Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences.

Plavén-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; De Picker L; Rusjan P; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Review: LANCET PSYCHIATRY. 2020;7(12):1064-1074

Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

Meyer JH; Cervenka S; Kim M-J; Kreisl WC; Henter ID; Innis RB
Letter: NEUROIMAGE. 2020;207:116371

In response to the letter "[11C]raclopride and extrastriatal binding to D2/3 receptors".

Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Corrigendum: NATURE NEUROSCIENCE. 2020;23(2):295

Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain.

Kaufmann T; van der Meer D; Doan NT; Schwarz E; Lund MJ; Agartz I; Alnæs D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Bøen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Córdova-Palomera A; Dale AM; de Quervain DJF; Di Carlo P; Djurovic S; Dørum ES; Eisenacher S; Elvsåshagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Håberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Høgestøl EA; Jernigan TL; Jonassen R; Jönsson EG; Karolinska Schizophrenia Project (KaSP); Kirsch P; Kłoszewska I; Kolskår KK; Landrø NI; Le Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbæk G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT
Letter: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(2):502-504

Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise.

Matheson GJ; Plavén-Sigray P; Tuisku J; Rinne J; Matuskey D; Cervenka S
Editorial comment: PSYCHOLOGICAL MEDICINE. 2019;49(10):1624-1628

Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?

Plavén-Sigray P; Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2019;208:490-492

Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.

Santillo AF; Lundgren S; Xu C; Orhan F; Fatouros-Bergman H; Blennow K; Zetterberg H; Portelius E; Karolinska Schizophrenia Project (KaSP) Consortium; Cervenka S; Jönsson EG; Erhardt S; Engberg G
Letter: BIOLOGICAL PSYCHIATRY. 2019;85(7):e35-e39

Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?

van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Clark VP; Mueller BA; de Zwarte SMC; Ophoff RA; van Haren NEM; Andreassen OA; Gurholt TP; Gruber O; Kraemer B; Richter A; Calhoun VD; Crespo-Facorro B; Roiz-Santiañez R; Tordesillas-Gutiérrez D; Loughland C; Catts S; Fullerton JM; Green MJ; Henskens F; Jablensky A; Mowry BJ; Pantelis C; Quidé Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Shannon Weickert C; Weickert TW; Hong E; Kochunov P; Gur RE; Gur RC; Ford JM; Macciardi F; Mathalon DH; Potkin SG; Preda A; Fan F; Ehrlich S; King MD; De Haan L; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; Pomarol-Clotet E; Kelly S; Ciufolini S; Radua J; Murray R; Marques TR; Simmons A; Borgwardt S; Schönborn-Harrisberger F; Riecher-Rössler A; Smieskova R; Alpert KI; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Yun J-Y; Cannon DM; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Karolinska Schizophrenia Project; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; McIntosh AM; Whalley HC; Knöchel C; Oertel-Knöchel V; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA
Review: NEUROSCIENCE LETTERS. 2019;691:26-34

PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders.

Cervenka S
Editorial comment: BRAIN BEHAVIOR AND IMMUNITY. 2018;74:43-44

Immune sculpting of the psychotic brain? In vivo associations between a glial cell marker and hippocampal morphology.

Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2018;199:438-441

Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients.

Checa A; Malmqvist A; Flyckt L; Schwieler L; Samuelsson M; Skogh E; Cervenka S; Dahl M-L; Piehl F; Karolinska Schizophrenia Project (KaSP) Consortium; Erhardt S; Wheelock CE
Letter: SCHIZOPHRENIA RESEARCH. 2018;195:406-408

First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction.

Orhan F; Fatouros-Bergman H; Schwieler L; Cervenka S; Flyckt L; Sellgren CM; Karolinska Schizophrenia Project (KaSP) consortium; Engberg G; Erhardt S
Review: PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2018;373(1744):20170156

Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.

Farde L; Plavén-Sigray P; Borg J; Cervenka S
Corrigendum: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(4):399

Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein (vol 3, pg 449, 2015)

van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Review: AGEING RESEARCH REVIEWS. 2017;36:50-63

In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.

Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Review: LAKARTIDNINGEN. 2015;112:DH34

[New findings about schizophrenia can provide new diagnostics and treatment].

Schalling M; Engberg G; Andreassen O; Erhardt S; Cunningham J; Agartz I; Petrovic P; Cervenka S; Fatouros-Bergman H
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2015;3(6):449-460

Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.

van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Letter: LAKARTIDNINGEN. 2013;110(32-33):1416-1417

[Greater clarity on scientific competence is needed].

Cervenka S; Runeson B; Lönnqvist P; Hedlund A; Grönvall KE; Flyckt L
Published conference paper: NEUROPSYCHOLOGIA. 2009;47(11):2299-2304

Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning.

MacDonald SWS; Cervenka S; Farde L; Nyberg L; Bäckman L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S7-S8

Limbic dopamine D2-receptor binding and social desirability

Cervenka S; Halldin C; Farde L
Meeting abstract: NEUROIMAGE. 2006;31:T85

Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction

Sovago J; Farde L; Cervenka S; Halldin C; Gulyas B
Show more

Employments

Senior Lecturer, Department of Clinical Neuroscience, Karolinska Institutet, 2021-

Degrees and Education

Docent, Karolinska Institutet, 2016
Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2008

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI